Catalyst Wire Dossier Catalyst Wire Dossier

Epanova

icosapent ethyl
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Epanova, covering 2007-02-21 to 2021-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia [Phase 3]

See pricing